88 related articles for article (PubMed ID: 3300974)
1. An evaluation of the effects of isosorbide 5-mononitrate in patients with angina on effort using dynamic electrocardiography and echocardiography.
Novo S; Nardi E; Alaimo G; Centineo G; Licata G; Strano A
Cardiology; 1987; 74 Suppl 1():20-8. PubMed ID: 3300974
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.
Quyyumi AA; Crake T; Wright CM; Mockus LJ; Fox KM
Br Heart J; 1987 Jun; 57(6):505-11. PubMed ID: 3304367
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.
Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG
Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380
[TBL] [Abstract][Full Text] [Related]
4. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
6. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of isosorbide-5-mononitrate on effort-induced electrocardiographic ischemic changes in patients with angina pectoris.
Brunner D; Meshulam N; Weisbort J
Int J Cardiol; 1987 Sep; 16(3):303-7. PubMed ID: 3654028
[TBL] [Abstract][Full Text] [Related]
8. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
Marten W; Weiss M; Haase W
Curr Med Res Opin; 1984; 9(2):96-106. PubMed ID: 6443349
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of isosorbide-5-mononitrate on painful and silent myocardial ischemia after myocardial infarction.
Feng JZ; Feng XH; Schneeweiss A
Am J Cardiol; 1990 Jun; 65(21):32J-35J. PubMed ID: 2190460
[TBL] [Abstract][Full Text] [Related]
10. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
[TBL] [Abstract][Full Text] [Related]
12. Isosorbide-5-mononitrate and nifedipine can reduce ischaemic ST-segment changes during Holter monitoring in patients with spontaneous angina pectoris.
von Arnim T; Erath A; Reuschel-Janetschek E
Eur Heart J; 1988 Jan; 9 Suppl A():113-8. PubMed ID: 3409907
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
[TBL] [Abstract][Full Text] [Related]
14. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the antianginal effect of isosorbide-5-mononitrate in patients with chronic stable angina pectoris.
Yasky J; Ontanilla E; Koch JE
Cardiology; 1991; 79 Suppl 2():27-30. PubMed ID: 1760826
[TBL] [Abstract][Full Text] [Related]
16. Isosorbide-5-mononitrate and atenolol in the treatment of stable exertional angina.
Waysbort J; Meshulam N; Brunner D
Cardiology; 1991; 79 Suppl 2():19-26. PubMed ID: 1760824
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of asymmetrical dosage timing of isosorbide-5-mononitrate on nitrate tolerance during long-term administration.
Hughes LO; DasGupta P; Jain D; Lahiri A; Raftery EB
Eur J Clin Pharmacol; 1989; 36(2):139-44. PubMed ID: 2498105
[TBL] [Abstract][Full Text] [Related]
18. Combined gallopamil and isosorbide-5-mononitrate in "mixed" angina pectoris.
Carboni GP; Saltarocchi ML; Risa AL; Scardovi AB; Zanchi E; Prati PL
J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S64-70. PubMed ID: 1284159
[TBL] [Abstract][Full Text] [Related]
19. Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy.
Thadani U; Prasad R; Hamilton SF; Voyles WF; Doyle R; Karpow SA; Reder R; Teague SM
Clin Pharmacol Ther; 1987 Jul; 42(1):58-65. PubMed ID: 3595067
[TBL] [Abstract][Full Text] [Related]
20. [Isosorbide 5-mononitrate (delayed release) in stable effort angina].
Almenar Bonet L; Miró Palau V; Gimeno Gascón JV; Algarra Vidal F
Rev Esp Cardiol; 1992; 45(7):456-61. PubMed ID: 1439070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
